1. Home
  2. CPAC vs PHAT Comparison

CPAC vs PHAT Comparison

Compare CPAC & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPAC
  • PHAT
  • Stock Information
  • Founded
  • CPAC 1949
  • PHAT 2018
  • Country
  • CPAC Peru
  • PHAT United States
  • Employees
  • CPAC N/A
  • PHAT N/A
  • Industry
  • CPAC Building Materials
  • PHAT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPAC Industrials
  • PHAT Health Care
  • Exchange
  • CPAC Nasdaq
  • PHAT Nasdaq
  • Market Cap
  • CPAC 497.5M
  • PHAT 423.4M
  • IPO Year
  • CPAC 2012
  • PHAT 2019
  • Fundamental
  • Price
  • CPAC $5.80
  • PHAT $5.01
  • Analyst Decision
  • CPAC Sell
  • PHAT Strong Buy
  • Analyst Count
  • CPAC 1
  • PHAT 5
  • Target Price
  • CPAC $6.00
  • PHAT $23.00
  • AVG Volume (30 Days)
  • CPAC 3.2K
  • PHAT 1.5M
  • Earning Date
  • CPAC 04-28-2025
  • PHAT 05-08-2025
  • Dividend Yield
  • CPAC 8.63%
  • PHAT N/A
  • EPS Growth
  • CPAC 17.75
  • PHAT N/A
  • EPS
  • CPAC 0.12
  • PHAT N/A
  • Revenue
  • CPAC $524,464,683.00
  • PHAT $55,252,000.00
  • Revenue This Year
  • CPAC N/A
  • PHAT $202.16
  • Revenue Next Year
  • CPAC N/A
  • PHAT $113.86
  • P/E Ratio
  • CPAC $9.48
  • PHAT N/A
  • Revenue Growth
  • CPAC 1.44
  • PHAT 8001.47
  • 52 Week Low
  • CPAC $5.10
  • PHAT $4.07
  • 52 Week High
  • CPAC $6.65
  • PHAT $19.71
  • Technical
  • Relative Strength Index (RSI)
  • CPAC 53.15
  • PHAT 41.86
  • Support Level
  • CPAC $5.71
  • PHAT $4.76
  • Resistance Level
  • CPAC $5.95
  • PHAT $6.26
  • Average True Range (ATR)
  • CPAC 0.02
  • PHAT 0.62
  • MACD
  • CPAC 0.01
  • PHAT -0.06
  • Stochastic Oscillator
  • CPAC 90.00
  • PHAT 24.30

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that primarily produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are primarily used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: